Pain & InflammationPrescriptionTablets

Vistflam-SP

Aceclofenac reduces joint tenderness, swelling and erythema.

Dosage Form
Tablets
Pack Sizes
10 × 10 Tablets
Status
Prescription
Business Enquiry →View Product ↓
Vistflam-SP Aceclofenac, Paracetamol and Serratiopeptidase tablets 10 × 10 carton
Product Overview

About Vistflam-SP

Vistflam-SP is a tablets formulation containing Aceclofenac, Paracetamol, Serratiopeptidase. Serratiopeptidase adds anti-inflammatory enzyme action.

FormTablets
Available In10 × 10 Tablets
ClassificationPrescription

  1. Step 01

    What is in the formula

    A 3-active formulation combining Aceclofenac, Paracetamol and Serratiopeptidase, transcribed from the composition panel exactly as printed.

    • Aceclofenac — 100 mg
    • Paracetamol — 325 mg
    • Serratiopeptidase — 15 mg

  2. Step 02

    How the dose is presented

    Presented as tablets in 10 × 10 Tablets. The pack panel carries the full handling direction.

    • Dosage form — Tablets
    • Pack size — 10 × 10 Tablets

  3. Step 03

    Where the prescriber directs it

    The pack prints 6 indications. They are reproduced on this page without addition; the prescribing decision stays with the physician.

    • Osteoarthritis
    • Rheumatoid arthritis
    • Ankylosing spondylitis
    • Dental extraction / surgery

  4. Step 04

    Dispensed under prescription

    The pack directs use in accordance with the advice of a Registered Medical Practitioner.

    • Prescription drug — for use under medical supervision.
Composition

Composition & Key Information

Composition of Vistflam-SP
IngredientStrength / Details
Aceclofenac100 mg
Paracetamol325 mg
Serratiopeptidase15 mg

Product Specifications

Brand NameVistflam-SP
Dosage FormTablets
Pack Sizes10 × 10 Tablets
Regulatory StatusPrescription
CategoryPain & Inflammation
DivisionPharmaceutical
Key actives

What each active is

No filler copy and no borrowed claims. Each card names an active exactly as the Vistflam-SP composition panel prints it, with its pharmacopoeial class and the strength on the carton.

  • Non-steroidal anti-inflammatory

    Aceclofenac

    100 mg

    Aceclofenac reduces joint tenderness, swelling and erythema.

  • Analgesic and antipyretic

    Paracetamol

    325 mg

  • Proteolytic enzyme

    Serratiopeptidase

    15 mg

    Serratiopeptidase adds anti-inflammatory enzyme action.

Product Highlights

Key Product Information

01

Aceclofenac reduces joint tenderness, swelling and erythema.

02

Serratiopeptidase adds anti-inflammatory enzyme action.

Indications

Therapeutic Indications

  • Osteoarthritis
  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Dental extraction / surgery
  • Traumatic injury
  • Primary dysmenorrhea

Course timeline

From the printed panel

The Vistflam-SP carton prints no onset, no duration of effect and no outcome, so none is published here. What it does document is a course — four phases, each carrying the panel text that governs it.

01Dispensing

Before the pack is opened

On the pack

  • Prescription drug — for use under medical supervision.

In practice

  • Confirm the classification printed on the carton — Tablets, 10 × 10 Tablets.

What follows

The pack leaves the counter intact, with its seal and batch details readable.

02First dose

Opening the pack

On the pack

  • The pack is used as supplied; no reconstitution step is printed.

In practice

  • Check the carton and its seal are intact and undamaged.
  • Read the batch number, manufacturing date and expiry printed on the pack.

What follows

From here the schedule belongs to the prescriber, not to the carton.

03The course

For as long as prescribed

On the pack

  • Dose and interval as directed by the prescriber.
  • The carton prints no schedule beyond this direction — 10 × 10 Tablets per pack, tablets.

In practice

  • Dose and interval are set by the prescriber — this page publishes no dosing schedule of its own.

What follows

What is left in the pack stays under the storage conditions printed on it.

04Storage & shelf

Between doses, and in the warehouse

On the pack

  • Store as printed on the carton.

In practice

  • Rotate stock first-expiry-first-out.

What follows

Expiry is the date printed on the carton — nothing on this page extends it.

Safety Information

Important Product Information

The following information is reproduced from the product packaging as supplied. Always read the product label before use.

Prescription drug — for use under medical supervision.

Packaging

Packaging & Availability

Vistflam-SP packaging

Available Pack Sizes

10 × 10 Tablets

Product Form

Tablets

Other Variants Available

Vistflam TabletsVistflam-P Tablets

Marketed By

Vistra Biotech Pharma

Patna, Bihar, India

Business Enquiry

Interested in Vistflam-SP?

Contact Vistra Biotech Pharma for distribution, PCD franchise, product dossiers, and business partnership opportunities for Vistflam-SP and the complete Vistflam product range.

Submit Business Enquiry →Call +91 91623 55919

Vistra Biotech Pharma — pharmaceutical marketing and distribution since June 2019.